Publications
- Ellipticine-loaded apoferritin nanocarrier retains DNA adduct-based cytochrome P450-facilitated toxicity in neuroblastoma cells2019 | Faculty of Science, Second Faculty of Medicine
- The Histone Deacetylase Inhibitor Valproic Acid Exerts a Synergistic Cytotoxicity with the DNA-Damaging Drug Ellipticine in Neuroblastoma Cells2018 | Faculty of Science, Second Faculty of Medicine
- Effectiveness of human cytochrome P450 3A4 present in liposomal and microsomal nanoparticles in formation of covalent DNA adducts by ellipticine2016 | Faculty of Science, Second Faculty of Medicine
- Vacuolar-ATPase-mediated intracellular sequestration of ellipticine contributes to drug resistance in neuroblastoma cells2015 | Faculty of Science, Second Faculty of Medicine
- Multilayered Polyurethane/Poly(vinyl alcohol) Nanofibrous Mats for Local Topotecan Delivery as a Potential Retinoblastoma Treatment2023 | Faculty of Science, Second Faculty of Medicine
- Lactate from the tumor microenvironment - A key obstacle in NK cell-based immunotherapies2022 | Faculty of Science, Central Library of Charles University
- Apoferritin/vandetanib association is long-term stable but does not improve pharmacological properties of vandetanib2021 | Faculty of Science, Second Faculty of Medicine
- Miat is an upstream regulator of nmyc and the disruption of the miat/nmyc axis induces cell death in nmyc amplified neuroblastoma cell lines2021 | Second Faculty of Medicine
- Poly(D,L-lactide)/polyethylene glycol micro/nanofiber mats as paclitaxel-eluting carriers: preparation and characterization of fibers, in vitro drug release, antiangiogenic activity and tumor recurrence prevention2019 | Faculty of Science, Second Faculty of Medicine, Third Faculty of Medicine
- Hydrogel implants for transscleral drug delivery for retinoblastoma treatment2019 | Second Faculty of Medicine
Loading network view...